EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
-15.59%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$869M
AUM Growth
+$869M
(-10%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
15.76%
Top 10 Holdings %
Top 10 Hldgs %
61.15%
Holding
62
New
17
Increased
11
Reduced
13
Closed
12
Top Buys
| 1 |
argenx
ARGX
|
$79.3M |
| 2 |
Xencor
XNCR
|
$35.8M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$35.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$27.5M |
| 5 |
Solid Biosciences
SLDB
|
$23.2M |
Top Sells
| 1 |
MacroGenics
MGNX
|
$31.8M |
| 2 |
Ascendis Pharma
ASND
|
$25.5M |
| 3 |
FibroGen
FGEN
|
$22.8M |
| 4 |
Scholar Rock
SRRK
|
$20.5M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$19.4M |
Sector Composition
| 1 | Healthcare | 89.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTSV
51
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| – | – |
-99,000
| Closed | -$1.48M |
|
|
KDMN
52
DELISTED
Kadmon Holdings, Inc.
KDMN
| – | – |
-1,480,870
| Closed | -$4.95M |
|
|
JNCE
53
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
0
| – | – |
|
|
APTX
54
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – |
-41,037
| Closed | -$1.19M |
|
|
INFI
55
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| – | – |
-462,068
| Closed | -$1.25M |
|
|
PHXM
56
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| – | – |
-69,569
| Closed | -$590K |
|
|
TECX
57
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| – | – |
-68,646
| Closed | -$3.56M |
|
58
Spero Therapeutics
SPRO
$117M
| – | – |
-892,741
| Closed | -$9.38M |
|
|
59
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
-254,000
| Closed | -$19.4M |
|
60
Nektar Therapeutics
NKTR
$543M
| – | – |
0
| – | – |
|
61
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-495,618
| Closed | -$4.96M |
|
|
62
MacroGenics
MGNX
$121M
| – | – |
-1,481,086
| Closed | -$31.8M |
|